Nutritional supplement to improve sleep quality
Official title: The Effects of a Nutritional Supplement on Sleep Quality
Run by Athletic Greens International · NCT07345260 · Data updated 2026-11-12
This trial will test whether a new powdered dietary supplement helps adults ages 35–65 with mild sleep problems sleep better than a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 35 Years to 65 Years |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Athletic Greens International Industry-sponsored |
| Locations | 1 site (Santa Monica, California) |
| Status | Recruiting |
| Started | January 2, 2026 |
| Main results expected | April 30, 2026 |
| Study ends | May 30, 2026 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT07345260 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 35–65 who are generally healthy, have a BMI between 18.5 and 29.9, report trouble falling or staying asleep with a RU-SATED score ≤7, are willing to stop other sleep supplements/OTC sleep aids, and reside in the United States.
✕Probably not a fit
People with diagnosed or uncontrolled chronic sleep disorders, uncontrolled chronic medical conditions, those outside the age or BMI ranges, or those unwilling to discontinue other sleep treatments are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, placebo-controlled trial enrolling 140 generally healthy adults with sub-clinical sleep problems (RU-SATED score ≤7). Participants are randomized to receive either the novel powdered supplement or a matching placebo and must stop other sleep-focused supplements or over-the-counter sleep aids for the study duration. Eligible participants are aged 35–65 with BMI 18.5–29.9 and must agree to limits on evening alcohol and caffeine intake. The single-site study is conducted at Citruslabs in Santa Monica, California, and compares sleep-related outcomes between groups.
Why it matters
Potential benefit: If successful, the supplement could provide a safe, non-prescription option to improve sleep onset, maintenance, and overall sleep quality for adults with mild sleep disturbances.
How similar studies have gone: Some individual nutritional supplements (for example, melatonin or magnesium) have shown modest, mixed benefits for sleep, but the specific supplement being tested here appears novel and not previously proven in large randomized trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Be male or female 2. Be aged 35-65. 3. Body Mass Index: ≥18.5 and ≤29.9 kg/m2 4. Anyone currently experiencing issues with falling asleep, staying asleep, or waking up during the night 5. Score of 7 or less on the RU-SATED validated sleep questionnaire. 6. Anyone willing to follow the study protocol. 7. Anyone willing to discontinue any other supplements (nootroptics, adaptogens, calming herbs), medications, herbal remedies, over the counter sleep medications \[e.g., zolipidem, diphenhydramine (Benadryl or unisom), magnesium or melatonin products\] used to assist with sleep for the duration of the study. 8. Agree to limit alcohol intake within \~4 hours of bedtime 9. Agree to limit caffeine intake to ≤ 400 mg/day (\~3-4 cups of coffee) or ingestion of caffeine-containing products after 2:00 PM during the study period. 10. Anyone who is generally healthy - does not live with any uncontrolled chronic disease. 11. Resides in the United States. Exclusion Criteria: 1. Anyone with a diagnosed chronic sleep condition, including but not limited to insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome (RLS), or sleep apnea. 2. Women currently undergoing perimenopause or experiencing vasomotor symptoms such as night sweats. 3. Use of hormone therapy (including estrogen, progesterone, or phytoestrogens) within the last 3 months. 4. Anyone with diagnosed psychiatric disorders including major depressive disorder with acute symptoms, Bipolar disorder, Generalized anxiety disorder with active symptoms, PTSD with frequent nightmares 5. Anyone with diagnosed neurogenitive diseases or chronic pain disorders including Parkinson's disease, Alzheimer's disease, or uncontrolled fibromyalgia 6. Anyone who regularly consumes prescribed stimulant medications including Amphetamines (e.g., Adderall, Vyvanse), Methylphenidate (e.g., Ritalin, Concerta), and Modafinil / Armodafinil 7. Anyone currently on CNS activating anti-depressants including Bupropion (Wellbutrin), Fluoxetine, Venlafaxine (Effexor), Sertraline (Zoloft). 8. Current or recent use of cannabis or THC-containing products, including recreational or medicinal marijuana, CBD products with measurable THC content, or synthetic cannabinoids, within the past 30 days. 9. Anyone with a job that disrupts their nighttime sleep (e.g., excessive travel, night/3rd shift workers). 10. Anyone unwilling to wear the Oura ring device for the duration of the trial or unwilling to open the Oura application at least three times each week during the trial for data to sync to the cloud 11. Anyone currently taking a prescription sleep aid. 12. Anyone who introduces any new supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of the study. 13. Anyone with any allergies or sensitivities to any of the study product ingredients. 14. Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period). 15. Anyone with a history of substance abuse. 16. Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men). 17. Currently partaking in another research study or will be partaking in any other research study for the next 7 weeks, or at any point during this study's duration.
Where it's running
-
Citruslabs
Santa Monica, California, United States Recruiting
Study contacts
- Principal investigator: Ellen O'Gorman — Citruslabs
- Study coordinator: Principal Investigator
- Email: ellen@citruslabs.com
- Phone: (805) 292-0714
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
Shoulder pain patients: see if breathing and chest exercises help pain and sleep
This study tests whether adding respiratory muscle strengthening and diaphragmatic breathing to shoulder rehab can reduce pain and improve sleep in adults with chronic shoulder pain.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
Ashwagandha with resistance training to boost strength and stress markers
This 12-week study tests whether taking ASHWAGANDHA along with regular resistance training helps healthy, trained men see improvements in strength, stress levels, sleep, and cognitive function compared with a placebo.
-
Acupoint Stimulation and Exercise for Pre-frail Older Adults in Taiwan
This study tests whether combining exercise with daytime and sleep-improving acupoint stimulation helps pre-frail adults 50 and older in Taiwan feel less frail and sleep better.
-
Sleep and Chronotype linked to Prosocial Choices
This observational study tests whether people’s sleep quality and chronotype relate to how they decide to allocate money in a hypothetical task.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.